Daniel Merk
Daniel Merk
ETH Zurich, Switzerland; Goethe University Frankfurt, Germany
Bekræftet mail på pharmchem.uni-frankfurt.de
Titel
Citeret af
Citeret af
År
Polypharmacology by design: a medicinal chemist’s perspective on multitargeting compounds
E Proschak, H Stark, D Merk
Journal of medicinal chemistry 62 (2), 420-444, 2018
1722018
De Novo Design of Bioactive Small Molecules by Artificial Intelligence
D Merk, L Friedrich, F Grisoni, G Schneider
Molecular informatics 37 (1-2), 1700153, 2018
1602018
Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008–present)
C Lamers, M Schubert-Zsilavecz, D Merk
Expert opinion on therapeutic patents 22 (7), 803-841, 2012
642012
Opportunities and challenges for fatty acid mimetics in drug discovery
E Proschak, P Heitel, L Kalinowsky, D Merk
Journal of medicinal chemistry 60 (13), 5235-5266, 2017
552017
Tuning artificial intelligence on the de novo design of natural-product-inspired retinoid X receptor modulators
D Merk, F Grisoni, L Friedrich, G Schneider
Communications Chemistry 1 (1), 1-9, 2018
512018
Nonacidic farnesoid X receptor modulators
D Flesch, SY Cheung, J Schmidt, M Gabler, P Heitel, J Kramer, A Kaiser, ...
Journal of medicinal chemistry 60 (16), 7199-7205, 2017
492017
Medicinal chemistry of farnesoid X receptor ligands: from agonists and antagonists to modulators
D Merk, D Steinhilber, M Schubert-Zsilavecz
Future medicinal chemistry 4 (8), 1015-1036, 2012
492012
A dual modulator of farnesoid X receptor and soluble epoxide hydrolase to counter nonalcoholic steatohepatitis
J Schmidt, M Rotter, T Weiser, S Wittmann, L Weizel, A Kaiser, J Heering, ...
Journal of medicinal chemistry 60 (18), 7703-7724, 2017
482017
Extending the structure–activity relationship of anthranilic acid derivatives as Farnesoid X receptor modulators: Development of a highly potent partial Farnesoid X receptor …
D Merk, C Lamers, K Ahmad, R Carrasco Gomez, G Schneider, ...
Journal of medicinal chemistry 57 (19), 8035-8055, 2014
452014
Small molecules with anti-inflammatory properties in clinical development
T Hanke, D Merk, D Steinhilber, G Geisslinger, M Schubert-Zsilavecz
Pharmacology & therapeutics 157, 163-187, 2016
442016
N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor γ Modulators
R Blöcher, C Lamers, SK Wittmann, D Merk, M Hartmann, L Weizel, ...
Journal of medicinal chemistry 59 (1), 61-81, 2016
372016
Scaffold hopping from natural products to synthetic mimetics by holistic molecular similarity
F Grisoni, D Merk, V Consonni, JA Hiss, SG Tagliabue, R Todeschini, ...
Communications Chemistry 1 (1), 1-9, 2018
362018
Generative molecular design in low data regimes
M Moret, L Friedrich, F Grisoni, D Merk, G Schneider
Nature Machine Intelligence 2 (3), 171-180, 2020
332020
Molecular tuning of farnesoid X receptor partial agonism
D Merk, S Sreeramulu, D Kudlinzki, K Saxena, V Linhard, SL Gande, ...
Nature communications 10 (1), 1-14, 2019
332019
Automated de novo molecular design by hybrid machine intelligence and rule-driven chemical synthesis
A Button, D Merk, JA Hiss, G Schneider
Nature machine intelligence 1 (7), 307-315, 2019
312019
Computer-assisted discovery of retinoid X receptor modulating natural products and isofunctional mimetics
D Merk, F Grisoni, L Friedrich, E Gelzinyte, G Schneider
Journal of medicinal chemistry 61 (12), 5442-5447, 2018
312018
DrugBank screening revealed alitretinoin and bexarotene as liver X receptor modulators
P Heitel, J Achenbach, D Moser, E Proschak, D Merk
Bioorganic & medicinal chemistry letters 27 (5), 1193-1198, 2017
302017
Anthranilic acid derivatives as novel ligands for farnesoid X receptor (FXR)
D Merk, M Gabler, RC Gomez, D Flesch, T Hanke, A Kaiser, C Lamers, ...
Bioorganic & medicinal chemistry 22 (8), 2447-2460, 2014
302014
NSAIDs Ibuprofen, Indometacin and Diclofenac do not interact with Farnesoid X Receptor
J Schmidt, FM Klingler, E Proschak, D Steinhilber, M Schubert-Zsilavecz, ...
Scientific reports 5 (1), 1-12, 2015
282015
Anthranilic acid derivatives as nuclear receptor modulators—Development of novel PPAR selective and dual PPAR/FXR ligands
D Merk, C Lamers, J Weber, D Flesch, M Gabler, E Proschak, ...
Bioorganic & medicinal chemistry 23 (3), 499-514, 2015
252015
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20